Patent · US Active

Inhibiting agents for bruton's tyrosine kinase

US11858926B2 · kind B2 · utility

0Cited by
8References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2022
Grant dateJan 2, 2024
Priority date
Expiry dateJul 22, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.